BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 12395691)

  • 1. Comparing the methods used to compare antidepressants.
    Thase ME
    Psychopharmacol Bull; 2002; 36 Suppl 1():Suppl 1-17; quiz Suppl 18-9. PubMed ID: 12395691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selection criteria and generalizability within the counterfactual framework: explaining the paradox of antidepressant-induced suicidality?
    Weisberg HI; Hayden VC; Pontes VP
    Clin Trials; 2009 Apr; 6(2):109-18. PubMed ID: 19342462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studying new antidepressants: if there were a light at the end of the tunnel, could we see it?
    Thase ME
    J Clin Psychiatry; 2002; 63 Suppl 2():24-8. PubMed ID: 15453011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imputing missing standard deviations in meta-analyses can provide accurate results.
    Furukawa TA; Barbui C; Cipriani A; Brambilla P; Watanabe N
    J Clin Epidemiol; 2006 Jan; 59(1):7-10. PubMed ID: 16360555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment effects of antidepressants in patients with post-stroke depression: a meta-analysis.
    Chen Y; Guo JJ; Zhan S; Patel NC
    Ann Pharmacother; 2006 Dec; 40(12):2115-22. PubMed ID: 17119102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression.
    Henkel V; Seemüller F; Obermeier M; Adli M; Bauer M; Mundt C; Brieger P; Laux G; Bender W; Heuser I; Zeiler J; Gaebel W; Mayr A; Möller HJ; Riedel M
    J Affect Disord; 2009 Jun; 115(3):439-49. PubMed ID: 19027961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relevance of exclusion criteria in antidepressant clinical trials: a replication study.
    Zetin M; Hoepner CT
    J Clin Psychopharmacol; 2007 Jun; 27(3):295-301. PubMed ID: 17502778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meta-analyses of mood stabilizers, antidepressants and antipsychotics in the treatment of borderline personality disorder: effectiveness for depression and anger symptoms.
    Mercer D; Douglass AB; Links PS
    J Pers Disord; 2009 Apr; 23(2):156-74. PubMed ID: 19379093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overview of studies of treatments for hand eczema-the EDEN hand eczema survey.
    Van Coevorden AM; Coenraads PJ; Svensson A; Bavinck JN; Diepgen TL; Naldi L; Elsner P; Williams HC;
    Br J Dermatol; 2004 Aug; 151(2):446-51. PubMed ID: 15327553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of study design on the results of continuation studies of antidepressants.
    Zimmerman M; Posternak MA; Ruggero CJ
    J Clin Psychopharmacol; 2007 Apr; 27(2):177-81. PubMed ID: 17414242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Meta-analysis of effectiveness and tolerability of treatment of mild to moderate depression with St. John's Wort].
    Röder C; Schaefer M; Leucht S
    Fortschr Neurol Psychiatr; 2004 Jun; 72(6):330-43. PubMed ID: 15211398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Which class of antidepressants is most effective and best tolerated by patients with major depression?
    Sparano N
    J Fam Pract; 2000 Oct; 49(10):886, 947-8. PubMed ID: 11052159
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy and effectiveness of antidepressants: current status of research.
    Pigott HE; Leventhal AM; Alter GS; Boren JJ
    Psychother Psychosom; 2010; 79(5):267-79. PubMed ID: 20616621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effectiveness of antidepressants. Implications of two meta-analyses for clinical practice].
    Thio S; van Balkom AJ
    Tijdschr Psychiatr; 2009; 51(12):887-91. PubMed ID: 20047168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Problems in determining efficacy and effectiveness of antidepressants.
    Möller HJ; Fountoulakis KN
    Psychiatriki; 2011; 22(4):298-306. PubMed ID: 22271842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Are phase II or phase II antidepressive drug studies still feasible considering currently required inclusion and exclusion criteria?].
    Steckler T; Hosten K; Müller-Oerlinghausen B
    Nervenarzt; 1993 Mar; 64(3):204-7. PubMed ID: 8479593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meta-analysis: fact or fiction? How to interpret meta-analyses.
    Huf W; Kalcher K; Pail G; Friedrich ME; Filzmoser P; Kasper S
    World J Biol Psychiatry; 2011 Apr; 12(3):188-200. PubMed ID: 21375365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of newer antidepressants.
    Buller R; Winter P; Ferner U
    J Clin Psychiatry; 1994 Nov; 55(11):499-500. PubMed ID: 7864967
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparing the effects of antidepressants: consensus guidelines for evaluating quantitative reviews of antidepressant efficacy.
    Lieberman JA; Greenhouse J; Hamer RM; Krishnan KR; Nemeroff CB; Sheehan DV; Thase ME; Keller MB
    Neuropsychopharmacology; 2005 Mar; 30(3):445-60. PubMed ID: 15647752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trial Simulation to estimate Type I error when a population window enrichment strategy is used to improve efficiency of clinical trials in depression.
    Gomeni R; Merlo-Pich E
    Eur Neuropsychopharmacol; 2012 Jan; 22(1):44-52. PubMed ID: 21636257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.